Tumor Cell-Induced Platelet Aggregation in Vitro by Human Pancreatic Cancer Cell Lines

References

• Nicolson GL. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sides. Biochim Biophys Acta 1988; 948: 175–224
   PubMed Web of Science ®Google Scholar
• Weiss L, Orr F W, Honn KV. Interactions between cancer cells and the microvasculature: a rate regulator for metastasis. Clin Exp Metast 1989; 7: 127–39
   PubMed Web of Science ®Google Scholar
• Yeatman T J, Nicolson GL. Molecular basis of tumor progression: mechanism of organ-specific tumor metastasis. Semin Surg Oncol 1993; 9: 256–63
   PubMedGoogle Scholar
• Jamieson G A, Bastida E, Ordinas A. Interaction of platelets and tumour cells. MacIntyre, Gordon, Platelets in biology and pathology III. Elsevier Science Publishers B.V., Biomedical Division, Amsterdam 1987; 161–89
   Google Scholar
• Gasic G J, Gasic T B, Galanti N, Johnson T, Murphy S. Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 1973; 11: 704–18
   PubMed Web of Science ®Google Scholar
• Honn K V, Tang D G, Crissman JD. Platelets and cancer metastasis: a causal relationship?. Cancer Metast Rev 1992; 11: 325–51
   PubMed Web of Science ®Google Scholar
• Grignani G, Pacchiarini L, Almasio P, Pagliarino M, Gamba G. Activation of platelet prostaglandin biosynthesis pathway during neoplastic cell-induced platelet aggregation. Thromb Res 1984; 34: 147–57
   PubMed Web of Science ®Google Scholar
• Chen Y Q, Liu B, Tang D G, Honn KV. Fatty acid modulation of tumor cell-platelet-vessel wall interaction. Cancer Metast Rev 1992; f11: 389–410
   Google Scholar
• Tsuruo T, Watanabe M, Oh-Hara T. Stimulation of the growth of metastatic clones of mouse colon adenocarcinoma 26 in vitro by platelet-derived growth factor. Jpn J Cancer Res 1989; 80: 136–40
   PubMedGoogle Scholar
• Menter D G, Hatfield J S, Harkins C J, Sloane B F, Taylor J D, Crissman J D, et al. Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells. Clin Exp Metast 1987; 5: 65–78
   PubMed Web of Science ®Google Scholar
• Crissman J D, Hatfield J S, Menter D G, Sloane B, Honn KV. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 1988; 48: 4065–72
   PubMed Web of Science ®Google Scholar
• Shau H, Roth M D, Golub SH. Regulation of natural killer function by nonlymphoid cells. Nat Immun 1993; 12: 235–49
   PubMedGoogle Scholar
• Philippe C, Philippe B, Fouqueray B, Perez J, Lebret M, Baud L. Protection from tumor necrosis factor-mediated cytolysis by platelets. Am J Pathol 1993; 143: 1713–23
   PubMed Web of Science ®Google Scholar
• Bastida E, Ordinas A, Giardina S L, Jamieson GA. Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospho-lipase. Cancer Res 1982; 42: 4348–52
   PubMed Web of Science ®Google Scholar
• Ugen K E, Mahalingam M, Klein P A, Kao KJ. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide. J Natl Cancer Inst 1988; 80: 1461–6
   PubMedGoogle Scholar
• Boukerche H, Berthier-Vergnes O, Tabone E, Dore J F, Leung L LK, McGregor JL. Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex. Blood 1989; 74: 658–63
   PubMed Web of Science ®Google Scholar
• Pearlstein E, Abrogio C, Gasic G, Karpatkin S. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine n-(3-ethyl-1,5-pentanediyl) amide. Cancer Res 1991; 41: 4535–9
   Google Scholar
• Tohgo A, Tanaka N G, Ogawa H. Platelet-aggregating activities of metastasizing tumor cells. Inv Metast 1985; 5: 96–105
   PubMedGoogle Scholar
• Esumi N, Todo S, Imashuku S. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res 1987; 47: 2129–35
   PubMed Web of Science ®Google Scholar
• Silberberg J M, Gordon S, Zucker S. Identification of tissue factor in two human pancreatic cancer cell lines. Cancer Res 1989; 49: 5443–7
   PubMed Web of Science ®Google Scholar
• Honn K V, Cavanaugh P, Evens C, Tailor D, Sloane BF. Tumor cell-platelet aggregation: Induced by cathepsin B-like proteinase and inhibited by prostacyclin. Science 1982; 217: 540–2
   PubMed Web of Science ®Google Scholar
• Pacchiarini L, Zucchella M, Milanesi G, Tacconi F, Bonomi E, Canevari A, et al. Thromboxane production by platelets during tumor cell-induced platelet activation. Inv Metast 1991; 11: 102–9
   PubMedGoogle Scholar
• Pacchiarini L, Grignani G, Pagliarino M, Ricetti M M, Bottazzi B, Mantovani A, et al. Role of tumor proteinases in tumor cell-induced platelet aggregation. Inv Metast 1986; 6: 287–301
   PubMedGoogle Scholar
• Grossi I M, Hatfield J S, Fitzgerald L A, Newcombe M, Taylor J D, Honn KV. Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions. FASEB J 1988; 2: 2385–95
   PubMed Web of Science ®Google Scholar
• Chopra H, Hatfield J S, Chang S Y, Grossi I M, Fitzgerald L A, O'Gara C Y, et al. Role of tumor cell cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell plasma membrane and tumor cell induced platelet aggregation. Cancer Res 1988; 48: 3787–800
   PubMed Web of Science ®Google Scholar
• Watanabe M, Okochi E, Sugimoto Y, Tsuruo T. Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr44,000 membrane protein as determined by monoclonal antibodies. Cancer Res 1988; 48: 6411–16
   PubMed Web of Science ®Google Scholar
• Katagiri Y, Hayashi Y, Baba I, Suzuki H, Tanoue K, Yamazaki H. Characterization of platelet aggregation induced by the human melanoma cell line HMV-1: roles of heparin, plasma adhesive proteins and tumor cell membrane proteins. Cancer Res 1991; 51: 1286–93
   PubMed Web of Science ®Google Scholar
• Karpatkin S, Pearlstein E, Ambrogio C, Coller BS. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 1988; 81: 1009–12
   Web of Science ®Google Scholar
• Heinrich D, Scharf T, Santoso S, Clemetoson K J, Müller-Eckhardt C. Monoclonal antibodies against human platelet membrane glycoproteins IIb-IIIa. II. Different effects on platelet function. Thromb Res 1985; 38: 547
   PubMed Web of Science ®Google Scholar
• Rosendahl A, Neumann K, Chaloupka B, Rothmund M, Weinel RJ. Expression and distribution of VLA-receptors in the pancreas: an immunohistochemical study. Pancreas 1993; 8: 711–8
   PubMed Web of Science ®Google Scholar
• Heinrich D, Santoso S, Scharf T, Weinel R J, Muller-Eckhardt C. Monoclonal platelet antibodies with Zw(a)-specificity have different inhibitory activity on platelet function. Monoclonal antibodies and human blood platelets, J L Mc Gregor. Elsevier, Amsterdam 1986; 167–72
   Google Scholar
• Suzuki H, Kinlough-Rathbone R L, Packham M A, Ta-Noue K, Yamazaki H, Mustard JF. Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphate-induced responses and enhanced fibrinogen binding in a medium with low calcium levels. Blood 1988; 71: 850–60
   PubMed Web of Science ®Google Scholar
• Honn K V, Tang D G, Chen YQ. Platelets and cancer metastasis: more than an epiphenomenon. Semin Thromb Hemost 1992; 18: 393–415
   Web of Science ®Google Scholar
• Crissman J D, Hatfield J, Schaldenbrand M, Sloane B F, Honn KV. Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study. Lab Invest 1985; 53: 470–8
   PubMed Web of Science ®Google Scholar
• Hamilton J, Subbarao V, Granack K, Ts'Ao C. Platelet interaction with a pancreatic ascites tumor. Am J Pathol 1986; 122: 160–8
   PubMed Web of Science ®Google Scholar
• Clezardin P, Serre C M, Trzeciak M C, Drouin J, Delmas PD. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction. Cancer Res 1991; 51: 2621–7
   PubMed Web of Science ®Google Scholar
• Lerner W A, Pearlstein E, Ambrogio C, Karpatkin S. A new mechanism for tumor-induced platelet aggregation. Comparison with mechanisms shared by other tumors with possible pharmacological strategy toward prevention of metastases. Int J Cancer 1983; 31: 463–9
   PubMed Web of Science ®Google Scholar
• Menter D G, Harkins C, Onoda J, Riorden W, Sloane B F, Taylor J D, et al. Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study. Inv Metast 1987; 7: 109–28
   PubMedGoogle Scholar
• Chopra H, Timar J, Rong X, Grossi I M, Hatfield J S, Fligiel S EG, et al. Is there a role for the tumor cell integrin α lib β3 and cytoskeleton in tumor cell-platelet interaction?. Clin Exp Metastasis 1992; 10: 125–37
   PubMed Web of Science ®Google Scholar
• Honn K V, Onoda J M, Menter D G, Taylor J D, Sloane BF. Prostacyclin in the control of tumor metastasis. Biol Protect Prostagland 1985; 1: 91–110
   Google Scholar
• Andren-Sandberg Å, Lecander I, Martinsson G, Åstedt B. Peaks in plasma plasminogen activator inhibitor-1 concentration may explain thrombotic events in cases of pancreatic carcinoma. Cancer 1992; 69: 2884–7
   PubMed Web of Science ®Google Scholar
• Nierodzik M L, Plotkin A, Kajumo F, Karpatkin S. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 1991; 87: 229–36
   PubMed Web of Science ®Google Scholar